← brief for 2026-10-12 · Slowing decline

Baseline anti-PLA2R antibody titer predicts treatment response and renal outcomes in rituximab-treated membranous nephropathy

Article C Peer reviewed Observational

Key takeaways

This study found that a specific blood test level before treatment can predict how well a kidney drug works. It looked at 69 patients with a rare kidney disease. It shows a link between test levels and outcomes, but it does not prove the test causes the result.

Who did this work

Jia Chen · Yuan Cheng · Hu Haofei · Dongli Qi · Mijie Guan · 宋海英 · 王国保 · 万启军

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-12
https://doi.org/10.1186/s40001-026-05288-7